产品编号 | 产品名称 | CAS No. |
DCAPI1202 |
Vecuronium Bromide
Vecuronium Bromide |
50700-72-6 |
DCAPI1231 |
Salinomycin (Procoxacin)
For the detailed information of Salinomycin (Procoxacin), the solubility of Salinomycin (Procoxacin) in water, the solubility of Salinomycin (Procoxacin) in DMSO, the solubility of Salinomycin (Procoxacin) in PBS buffer, the animal experiment(test) (test) |
53003-10-4 |
DCAPI1374 |
Cyclovirobuxin D(Bebuxine)
Cyclovirobuxin D(Bebuxine) |
860-79-7 |
DCAPI1391 |
Ranolazine (Ranexa)
Ranolazine (Ranexa) |
95635-55-5 |
DCAPI1393 |
Nedaplatin (Aqupla)
Nedaplatin (Aqupla) is a derivative of cisplatin for inhibition of tumor colony forming units with IC50 of 28.5 μg/mL. |
95734-82-0 |
DCAPI1398 |
Disulfiram (Antabuse)
Disulfiram (Antabuse) |
97-77-8 |
DCAPI1411 |
Bisoprolol Fumarate
(±)-Bisoprolol hemifumarate is a selective β1-AR adrenergic antagonist. Possesses β1/β2 selectivity of approximately 100-fold and a Kd of 2-3 nM at the β1-AR (β1 receptor). |
104344-23-2 |
DCAPI1425 |
Anastrozole
Anastrozole is known to inhibit the CYP19 enzyme (aromatase, IC50 = 15 nM) that converts androgens to estrogens. Anastrozole has been seen to reversibly bind to the CYP19 enzyme through competitive inhibition. |
120511-73-1 |
DCAPI1434 |
Romidepsin(FK-228)
Romidepsin strongly inhibits HDAC1 and HDAC2 with IC50 of 1.6 nM and 3.9 nM, respectively, but is relatively weak in inhibiting HDAC4 and HDAC6 with IC50 25 nM and 790 nM, respectively. |
128517-07-7 |
DCAPI1436 |
Milbemycin oxime
Milbemycin oxime is a semi-synthetic macrocyclic lactone prepared by the oxidation and oximation of a mixture of two natural products, milbemycin A3 and A4 (in ~70: 30 ratio). Moxidectin oxime, marketed as Interceptor, is used therapeutically for the prev |
129496-10-2 |
DCAPI1442 |
Atorvastatin Calcium
Atorvastatin Calcium |
134523-03-8 |
DCAPI1451 |
Voriconazole
Voriconazole is an ergosterol biosynthesis inhibitor, as well as systemic antifungal. This compound, like many antifungal agents, is an inhibitor of CYP2C9, an enzyme involved in the oxidative metabolism of many xenobiotics. |
137234-62-9 |
DCAPI1468 |
Rosuvastatin Calcium
A selective, competitive inhibitor of HMG-CoA reductase, that is also antilipemic. |
147098-20-2 |
DCAPI1473 |
Pregabalin
Pregabalin |
148553-50-8 |
DCAPI1480 |
rosiglitazone maleate
Rosiglitazone Maleate is an insulin sensitizer. Exhibits binding to PPARγ. This compound has the effect of lowering blood glucose as well as levels of insulin. |
155141-29-0 |
DCAPI1491 |
Celecoxib
Celecoxib is a selective Cox-2 inhibitor (IC50 of 40 nM). Celecoxib shows low sensitivity against Cox-1 (IC50 of 15 μM). Celecoxib shows an anti-proliferative effect on nasopharyngeal carcinoma (NPC) cell lines including HNE1 (IC50of 32.86 μM) and CNE1-LM |
169590-42-5 |
DCAPI1512 |
Lapatinib
Lapatinib |
231277-92-2 |
DCAPI1520 |
S-adenosyl-L-methionine
S-adenosyl-L-methionine |
29908-03-0 |
DCAPI1525 |
5-Azacytidine
5-Azacytidine is a potent growth inhibitor and a cytotoxic agent. 5-Azacytidine acts as a demethylating agent by inhibiting DNA methyltransferase (Dnmt), forming covalent adducts with cellular DNMT1 depleting enzyme activity. 5-Azacytidine also improves t |
320-67-2 |
DCAPI1552 |
streptomycin
streptomycin |
57-92-1 |
DCAPI1560 |
Sitagliptin phosphate
Sitagliptin phosphate, an orally active agent, potently inhibits CD26 (DPP-4) with an IC50 of 19 nM. Sitagliptin performs a direct, novel action in order to stimulate GLP-1 secretion by the intestinal L cell through a DPP-4-independent, protein kinase A- |
654671-77-9 |
DCAPI1581 |
Raltegravir
Raltegravir Salt is a potent human immunodeficiency virus (HIV) integrase inhibitor and a novel anti-AIDS drug. |
518048-05-0 |